Related Experiment Video
Updated: Oct 11, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis?
1Department of Nephrology, Baskent University Faculty of Medicine, Ankara, Turkey.
Insights
Continuous ambulatory peritoneal dialysis (CAPD) shows better short-term outcomes than hemodialysis (HD) for patients with improved nutritional status, hypertension, and anemia control.
Area of Science:
- Nephrology
- Internal Medicine
- Clinical Research
Background:
- End-stage renal disease necessitates renal replacement therapy.
- Hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) are common treatment modalities.
- Patient outcomes can vary significantly between HD and CAPD.
Purpose of the Study:
- To compare the clinical and laboratory outcomes of patients switching from HD to CAPD.
- To evaluate the short-term efficacy of CAPD versus ongoing HD treatment.
Main Methods:
- Prospective study following 34 patients after transitioning from HD to CAPD.
- Data collection included clinical parameters, laboratory values (hemoglobin, ferritin, lipids, etc.), body composition, echocardiography, and medications.
- Patients were followed for a mean of 19.8 months post-transition.
Main Results:
- CAPD led to significant increases in hemoglobin, cholesterol, triglycerides, HDL, Lp(a), phosphorus, and iPTH.
- Erythropoietin dosage and ferritin levels decreased.
- Blood pressure, left ventricular hypertrophy, and cardiac dysfunction significantly improved.
- Nutritional status (total protein, BMI, triceps skin fold) showed significant improvement.
Conclusions:
- CAPD demonstrates superior short-term outcomes compared to HD.
- CAPD offers better control of anemia and hypertension.
- CAPD improves the nutritional status of patients with end-stage renal disease.
Abstract:
A prospective study was planned to follow the clinical and laboratory data of hemodialysis (HD) patients after change of treatment to continuous ambulatory peritoneal dialysis (CAPD). Patients who had been on the HD program for more than 6 months were selected and followed for at least 6 months under CAPD treatment. Measured parameters included hemoglobin, ferritin, C-reactive protein (CRP), calcium, phosphorus, and intact parathyroid hormone (iPTH) levels; lipid profile; total protein and albumin; body mass index and triceps skin fold thickness; echocardiographic findings; and medications administered. We followed 34 patients (12 males, 22 females; mean age: 43.5 +/- 14.5 years; mean HD duration: 36.6 +/- 24.76 months) for a mean period of 19.8 +/- 11.9 months after change of treatment to CAPD. We saw a significant increase in mean hemoglobin, cholesterol, triglyceride, high-density lipoprotein (HDL), lipoprotein (a) [Lp(a)], phosphorus, and iPTH levels. We observed a decrease in erythropoietin dose, mean ferritin levels, systolic blood pressure (139.4 +/- 22.8 mmHg vs 114.4 +/- 21.0 mmHg, p = 0.001), diastolic blood pressure (85.7 +/- 12.6 mmHg vs 73.5 +/- 17.6 mmHg, p = 0.002), percentage of left ventricular hypertrophy, systolic and diastolic dysfunction, and the number of hypertensive drugs received. A significant improvement in the nutritional status of the patients (total protein, body mass index and triceps skin fold thickness) was also seen. In conclusion, CAPD treatment has a short-term outcome superior to that of HD in terms of better nutritional status and better control of hypertension and anemia.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Hemodialysis II: Procedure and Complications

